Bruxism and Severity of Temporomandibular Dsyfunction

Temporomandibular Dysfunction Clinical Trial

Official title:

The Effect of Bruxism on Masticatory Functionality and Severity of Temporomandibular Dsyfunction: A Cross-sectional Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06053723
• Other study ID #: 2023-54
• Status: Completed
• Start date: April 15, 2023
• Est. completion date: September 15, 2023

Study information

• Verified date: September 2023
• Source: Bandirma Onyedi Eylül University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of the study was to investigate the effect of bruxism on Temporomanbular joint functionality and dysfunction severity in individuals with Temporomandibular Dysfunction (TMD).

Description:

The study included 91 individuals aged 20-55 years with TMD. Participants who volunteered to participate in the study signed the Informed Consent Form and completed the Descriptive Data Form including demographic characteristics. The presence of bruxism in individuals with TMD was questioned and the maximum mouth opening measurement was recorded. TMD severity was assessed by Fonseca's Anamnestic Questionnaire (FAQ), pain severity was assessed by Numeric Pain Scale (NPS), and masticatory and TMJ functioning was assessed by JAW Functional Limitation Scale-20 (JFLS-20). The evaluations of the participants were performed only once.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 91
• Est. completion date: September 15, 2023
• Est. primary completion date: September 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 55 Years

Eligibility

Inclusion Criteria:

• Aged between 20 and 55 years,
• Diagnosed with TMD,
• volunteer to participate in the study

Exclusion Criteria:

• having a non-reduced disc problem,
• surgical operation due to spine, abdomen and/or TMJ problem,
• trauma, cancer, neurological problems, congenital anomalies, musculoskeletal system problems,
• systemic disease,
• facial paralysis
• Less than 6 months of receiving any treatment related to the spine and TMJ

Related Conditions & MeSH terms

• Bruxism
• Temporomandibular Dysfunction
• Temporomandibular Joint Disorders
• Temporomandibular Joint Dysfunction Syndrome

Intervention

Other:
• Fonseca's Anamnestic Questionnaire
The questionnaire includes 10 questions about joint, head and neck pain, pain during masticatory activity, parafunctional habits, decreased joint motion, impaired occlusion and emotional stress.
• Numeric Pain Scale
It is a simple, reliable and short-term method that is frequently used to measure pain intensity in the clinic.
• Jaw Functionality Limitation Scale-20
It includes a total of 20 items, with "0" indicating no limitation and "10" indicating severe limitation in each item, about the function of the TMJ during different activities, difficulty in chewing and jaw limitation.

Locations

Country	Name	City	State
Turkey	Bandirma Onyedi Eylul University	Balikesir

Sponsors (1)

Lead Sponsor	Collaborator
Bandirma Onyedi Eylül University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Bruxism evaluation	Sleep bruxism reported by the individual was recorded. As clinical diagnostic criteria for bruxism; the presence of regular or frequent teeth clenching and grinding sounds followed by pain or fatigue in the jaw muscles on waking up in the morning, temporal headache, masseter muscle hypertrophy, abnormal tooth abrasion and/or jaw locking were questioned and the presence of one or more clinical findings was recorded as bruxism.	April 2023- September 2023
Primary	Maximum mouth opening	Maximum pain-free mouth opening was measured with a 15 cm ruler	April 2023- September 2023
Primary	Severity of Temporomandibular dysfunction	Fonseca's Anamnestic Questionnaire (FAQ) was used. The questionnaire includes 10 questions about joint, head and neck pain, pain during masticatory activity, parafunctional habits, decreased joint motion, impaired occlusion and emotional stress. As a result of the questionnaire, the presence of TMD is accepted in patients with a score of 25 and above, and the severity can be classified as mild TMJ disorder (25-45), moderate TMJ disorder (50-65) and severe TMJ disorder (70-100).	April 2023- September 2023
Primary	Pain intensity	Numeric Pain Scale (NAS): It is a simple, reliable and short-term method commonly used in the clinic to measure pain intensity. The patient is told that the most severe pain he/she feels in the TMJ region is 10, and if there is no pain, the pain intensity is 0. The participant was asked to say a number between 0 and 10 corresponding to the intensity of pain felt in the TMJ region.	April 2023- September 2023
Primary	Jaw Functionality	Jaw Functionality Limitation Scale-20 was used. It includes a total of 20 items, with "0" indicating no limitation and "10" indicating severe limitation in each item, about the function of the TMJ during different activities, difficulty in chewing and jaw limitation. As a result of the questionnaire, it was reported that TMJ function was limited in individuals with a score of 5 and above.	April 2023- September 2023